Crescent Biopharma 宣布与 Kelun-Biotech 达成重大合作,并进行 1.85 亿美元私人配售,推动和扩展全球下一代实体肿瘤治疗药物的管道。
Crescent Biopharma 宣布与 Kelun-Biotech 达成重大合作,并进行 1.85 亿美元私人配售,推动和扩展全球下一代实体肿瘤治疗药物的管道。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.